3/27
08:00 am
vor
Vor Bio Announces $75 Million Private Placement with TCGX
Medium
Report
Vor Bio Announces $75 Million Private Placement with TCGX
3/23
04:30 pm
vor
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/19
09:00 am
vor
Vor Biopharma (VOR) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $30.00 price target on the stock.
Low
Report
Vor Biopharma (VOR) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $30.00 price target on the stock.
2/23
08:00 am
vor
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
High
Report
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
1/23
05:09 am
vor
Vor Biopharma (NASDAQ:VOR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Vor Biopharma (NASDAQ:VOR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/9
08:02 am
vor
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Low
Report
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $50.00 price target on the stock.
1/6
08:00 am
vor
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference